Broken redirects
Jump to navigation
Jump to search
The following redirects link to non-existent pages:
Showing below up to 50 results in range #1,971 to #2,020.
- Systolic blood pressure intervention → Systolic Blood Pressure Intervention Trial
- Systolic Blood Pressure Intervention → Systolic Blood Pressure Intervention Trial
- A Randomized Trial of Intensive versus Standard Blood-Pressure Control → Systolic Blood Pressure Intervention Trial
- A Randomized Trial of Intensive versus Standard Blood Pressure Control → Systolic Blood Pressure Intervention Trial
- A randomized trial of intensive versus standard blood pressure control → Systolic Blood Pressure Intervention Trial
- Randomized trial of intensive versus standard blood pressure control → Systolic Blood Pressure Intervention Trial
- Randomized trial of intensive versus standard blood-pressure control → Systolic Blood Pressure Intervention Trial
- A randomized trial of intensive versus standard blood-pressure control → Systolic Blood Pressure Intervention Trial
- SPRINT trial → Systolic Blood Pressure Intervention Trial
- SPRINT Trial → Systolic Blood Pressure Intervention Trial
- Syst-China → Systolic Hypertension In China Trial
- SHEP → Systolic Hypertension In Elderly Program
- ALPHA → T-Wave Alternans In Patients With Heart Failure
- Pediatric T-cell leukemia → T-cell acute lymphoblastic leukemia
- Precursor T acute lymphoblastic leukemia/lymphoma → T-cell acute lymphoblastic leukemia
- Pre-T ALL → T-cell acute lymphoblastic leukemia
- Mature T ALL → T-cell acute lymphoblastic leukemia
- Lymphomatous T-cell leukemia/lymphoma → T-cell acute lymphoblastic leukemia
- Cortical T ALL → T-cell acute lymphoblastic leukemia
- Pro-T ALL → T-cell acute lymphoblastic leukemia
- T-acute lymphoblastic lymphoma → T-cell acute lymphoblastic leukemia
- T-ALL → T-cell acute lymphoblastic leukemia
- T-LBL → T-cell acute lymphoblastic leukemia
- Takeda Pharmaceuticals → Takeda Pharmaceutical Company
- Takeda Pharmaceutical Co. → Takeda Pharmaceutical Company
- Takeda Pharmaceutical → Takeda Pharmaceutical Company
- THUNDER → Taxan With Short Time For Contact For Reduction Of Restenosis In Distal Arteries
- TEN-HMS → Telemonitoring For Heart Failure: Patient Characteristics And First Results
- TRANSCEND → Telmisartan Randomised Assessment Study In Ace Intolerant Subjects With Cardiovascular Disease
- Tergite → Tergum
- TRENDS → Tetra Randomized European Direct Stenting Study
- Tetrahedral → Tetrahedron
- Tetrapods → Tetrapod
- Protophyta → Thallophyte
- ACCEPT → The Accupril Canadian Clinical Evaluation And Patient Teaching Study
- Air PAMI → The Air Primary Angioplasty In Myocardial Infarction Study
- ATRIA → The Anticoagulation And Risk Factors In Atrial Fibrillation Study
- ASSENT 3 → The Assessment Of The Safety And Efficacy Of A New Thrombolytic Regimen (Assent)-3 Investigators. Efficacy And Safety Of Tenecteplase In Combination With Enoxaparin, Abciximab, Or Unfractionated Heparin: The Assent-3 Randomized Trial In Acute Mi
- ACTIVE A → The Atrial Fibrillation Clopidogrel Trial With Irbesartan For Prevention Of Vascular Events
- AIRCRAFT → The Australian Intervention Randomized Control Of Rate In Atrial Fibrillation Trial
- CARET → The Beta Carotene And Retinol Efficacy Trial
- CAST-II → The Cardiac Arrhythmia Suppression Trial II
- CAPS → The Cardiac Arrhythmic Pilot Study
- CIBIS II → The Cardiac Insufficiency Bisoprolol Study II
- CIBIS III → The Cardiac Insufficiency Bisoprolol Study III
- CARMEN → The Carvedilol And Ace-Inhibitor Remodeling Mild Heart Failure Evaluation Trial
- CCP → The Cooperative Cardiovascular Project
- CABG PATCH → The Coronary Artery Bypass Graft Patch Trial
- MEXIS → The Effects Of B-Receptor Antagonists In Patients With Clinical Evidence Of Heart Failure After Myocardial Infarction: Double Blind Comparison Of Meto
- CONSENSUS → The Effects Of Enalapril On Mortality In Severe Congestive Heart Failure